US Department of War Announces $80 Million Loan for Domestic Pharmaceutical Production

The Trump administration's Department of War has committed an $80 million conditional loan to Antheia, a biotechnology company, to boost domestic manufacturing of essential pharmaceutical ingredients. This initiative aims to reduce the nation's reliance on foreign suppliers for critical medicines, treating pharmaceutical supply chains as a national security priority. The funding is conditional on Antheia meeting various requirements.